黑料网

Journal of Diabetes & Clinical Practice
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Perspective   
  • JDCE,
  • DOI: 10.4172/jdce.1000169

Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice

Yan Wang*
Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, US
*Corresponding Author : Yan Wang, Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, US, Email: Yanwang90@gmail.com

Received Date: Nov 01, 2022 / Accepted Date: Nov 30, 2022 / Published Date: Nov 30, 2022

Abstract

Endogenous ligands for peroxisome proliferator-activated receptors include nitrooleic acid. The goal of the current investigation was to examine the therapeutic effects of OA-NO2 on lipid metabolism and hepatic steatosis in a mouse model of hypertension caused by deoxycorticosterone acetate salt. Male C57BL/6 mice were separated into two groups: one group got neither DOCA-salt nor OA-NO2, and the other received neither DOCA-salt nor OA-NO2 (control group). The hypertension was detected after a 3-week course of therapy with DOCA-salt + 1% sodium chloride in drinking water; however, OA-NO2 had no impact on the hypertension. Plasma triglyceride and total cholesterol levels in DOCA-salt-treated animals were considerably higher than those in control mice, but these parameters were markedly decreased after pretreatment with OA-NO2. Additionally, the histology of the liver showed increased lipid distribution along with more severe micro- and following DOCA-salt therapy, there was macro vesicular steatosis, which was consistent with the level of triglycerides and non-esterified fatty acids in the liver tissue.

Citation: Wang Y (2022) Lipid Metabolic Disorders and Liver Steatosis in DOCASalt Hypertensive Mice. J Diabetes Clin Prac 5: 169. Doi: 10.4172/jdce.1000169

Copyright: © 2022 Wang Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top